Hamad Medical Corporation has received international accreditation in the field of nuclear medicine, represented by the nuclear medicine and molecular imaging section of the Clinical Imaging Department.
The section received the Radiopharmaceutical Therapy Center of Excellence accreditation from the Society of Nuclear Medicine and Molecular Imaging, becoming one of the first centres outside the United States to receive this prestigious recognition.
The accreditation reflects Hamad Medical Corporation’s commitment to providing advanced and high-quality radiopharmaceutical therapy services in line with the highest international standards.
The nuclear medicine and molecular imaging section continues to focus on delivering precise, personalised and targeted treatments that help improve treatment outcomes and enhance the patient experience.
Dr Maryam Al Kuwari, Senior Consultant Radiologist and Chief Radiologist at Hamad Medical Corporation, said the international recognition reflects the excellence of the corporation’s capabilities in this field, as well as its focus on patient safety and providing treatments designed to meet patients’ individual needs.
She also reaffirmed the corporation’s commitment to the continuous development of nuclear medicine services.
The nuclear medicine and molecular imaging section currently provides treatments for six types of benign and malignant tumours, reflecting its growing capabilities and leadership in this specialised field.
The section also continues to expand its services and promote innovation to meet the growing needs of patients in Qatar and beyond.
Follow the latest news, events, sports updates, business, real estate and lifestyle stories through Qatar Living, the leading online platform for residents and visitors in Qatar.
Follow Qatar Living for daily updates:
Instagram - @qatarliving
X - @qatarliving
Facebook - Qatar Living
YouTube - qatarlivingofficial
